No Data
No Data
pku healthcare corp. (000788.SZ) plans to distribute a cash dividend of 0.5 yuan per 10 shares, with ex-rights and ex-dividends on November 27.
pku healthcare corp. (000788.SZ) announced that the proposed interim equity distribution for the first half of 2024 is: to all shareholders of the company...
pku healthcare corp. (000788.SZ): Paroxetine Hydrochloride Enteric-Coated Sustained-Release Tablets Approved.
格隆汇 October 29th | pku healthcare corp. (000788.SZ) announced that recently, pku healthcare corp. limited received the "Drug Registration Certificate" of Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets issued by the National Medical Products Administration. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets (hereinafter referred to as "Paroxetine Enteric-coated Sustained-release Tablets") is a potent, highly selective selective serotonin reuptake inhibitor (SSRI) that enhances central serotonin nerve function by increasing serotonin concentrations in the synaptic cleft, improving depressive symptoms. Currently, Paroxetine has been recommended by multiple domestic and foreign treatment guidelines for the treatment of depression.
Peking University Pharmaceuticals: Report for the third quarter of 2024
pku healthcare corp., (000788.SZ) released its performance for the first three quarters, with a net income of 0.13 billion yuan, a year-on-year increase of 182.49%.
pku healthcare corp. (000788.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue...
pku healthcare corp. (000788.SZ): net income of 0.13 billion yuan in the first three quarters, an increase of 182.49% year-on-year.
Pku healthcare corp., (000788.SZ) announced its third-quarter report on October 25th. In the first three quarters of 2024, the company achieved revenue of 1.534 billion yuan, a year-on-year decrease of 7.32%; net income attributable to shareholders of the listed company was 0.13 billion yuan, a year-on-year increase of 182.49%; net income after deducting non-recurring gains and losses was 0.13 billion yuan, a year-on-year increase of 221.85%; basic earnings per share were 0.2187 yuan per share.
PKU HealthCareLtd (SZSE:000788) Is Posting Promising Earnings But The Good News Doesn't Stop There
No Data
No Data